Vault-13

Kalehua Capital Management LLC

DALLAS, TX · CIK 2106181 · 13F filing filed 2026-08-14

Exempt reporting adviser since 2023 · limited liability company

$313.5m reported value +20.6% vs Q1 2026
26positions
70.1%in top 10
8 new 5 added 3 reduced 7 sold out vs Q1 2026

Holdings, Q2 2026

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 VERADERMICS INC COMMON STOCK MANE MANE 291,390 $35.8m11.43% 11.43% AddedShares held: Q3 2025 —, Q4 2025 0, Q1 2026 248.6k, Q2 2026 291.4k +42.8k +42,816 17.2%
2 X4 PHARMACEUTICALS INC COM NEW XFOR XFOR 7,445,680 $34.8m11.09% 11.09% UnchangedShares held: Q3 2025 —, Q4 2025 3.7m, Q1 2026 7.4m, Q2 2026 7.4m
3 EA SERIES TRUST ALPHA ARCH 1-3 BOXX BOXX 226,188 $26.5m8.45% 8.45% ReducedShares held: Q3 2025 —, Q4 2025 230.8k, Q1 2026 336.7k, Q2 2026 226.2k -110.5k -110,512 -32.8%
4 COMPASS PATHWAYS PLC SPONSORED ADS CMPS CMPS 1,639,384 $23.2m7.40% 7.40% UnchangedShares held: Q3 2025 —, Q4 2025 819.7k, Q1 2026 1.6m, Q2 2026 1.6m
5 SURROZEN INC COM NEW SRZN SRZN 770,356 $20.0m6.38% 6.38% UnchangedShares held: Q3 2025 —, Q4 2025 385.2k, Q1 2026 770.4k, Q2 2026 770.4k
6 ACLARIS THERAPEUTICS INC COM ACRS ACRS 3,664,730 $19.4m6.18% 6.18% AddedShares held: Q3 2025 —, Q4 2025 0, Q1 2026 3.2m, Q2 2026 3.7m +494.8k +494,809 15.6%
7 SIONNA THERAPEUTICS INC COM SION SION 394,144 $17.3m5.53% 5.53% UnchangedShares held: Q3 2025 —, Q4 2025 197.1k, Q1 2026 394.1k, Q2 2026 394.1k
8 INHIBIKASE THERAPEUTICS INC COM NEW IKT IKT 7,643,780 $15.5m4.95% 4.95% AddedShares held: Q3 2025 —, Q4 2025 1.8m, Q1 2026 6.5m, Q2 2026 7.6m +1.1m +1,149,282 17.7%
9 PHARVARIS N V COM PHVS PHVS 397,544 $13.7m4.39% 4.39% UnchangedShares held: Q3 2025 —, Q4 2025 198.8k, Q1 2026 397.5k, Q2 2026 397.5k
10 KARYOPHARM THERAPEUTICS INC COM NEW KPTI KPTI 1,371,288 $13.4m4.27% 4.27% NewShares held: Q3 2025 —, Q4 2025 0, Q1 2026 0, Q2 2026 1.4m
11 SEPTERNA INC COM SEPN SEPN 389,088 $13.0m4.16% 4.16% UnchangedShares held: Q3 2025 —, Q4 2025 194.5k, Q1 2026 389.1k, Q2 2026 389.1k
12 INFLARX NV COM IFRX IFRX 5,795,538 $13.0m4.14% 4.14% NewShares held: Q3 2025 —, Q4 2025 0, Q1 2026 0, Q2 2026 5.8m
13 CYCLERION THERAPEUTICS INC COM COM 3,302,700 $11.2m3.57% 3.57% NewShares held: Q3 2025 —, Q4 2025 0, Q1 2026 0, Q2 2026 3.3m
14 UNIQURE NV SHS QURE QURE 158,814 $7.3m2.33% 2.33% ReducedShares held: Q3 2025 —, Q4 2025 0, Q1 2026 502.8k, Q2 2026 158.8k -344.0k -343,997 -68.4%
15 LEONABIO INC COM LONA LONA 787,402 $7.2m2.31% 2.31% UnchangedShares held: Q3 2025 —, Q4 2025 393.7k, Q1 2026 787.4k, Q2 2026 787.4k
16 DAMORA THERAPEUTICS INC COM NEW COM NEW 278,000 $7.2m2.31% 2.31% UnchangedShares held: Q3 2025 —, Q4 2025 0, Q1 2026 278.0k, Q2 2026 278.0k
17 MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD MLTX MLTX 351,468 $6.8m2.18% 2.18% UnchangedShares held: Q3 2025 —, Q4 2025 175.7k, Q1 2026 351.5k, Q2 2026 351.5k
18 KORRO BIO INC COM KRRO KRRO 405,040 $5.3m1.70% 1.70% AddedShares held: Q3 2025 —, Q4 2025 0, Q1 2026 109.4k, Q2 2026 405.0k +295.7k +295,664 270.3%
19 TYRA BIOSCIENCES INC COM TYRA TYRA 148,930 $4.8m1.52% 1.52% UnchangedShares held: Q3 2025 —, Q4 2025 74.5k, Q1 2026 148.9k, Q2 2026 148.9k
20 NUVECTIS PHARMA INC COM NVCT NVCT 200,000 $3.7m1.17% 1.17% NewShares held: Q3 2025 —, Q4 2025 0, Q1 2026 0, Q2 2026 200.0k
21 GOSSAMER BIO INC COM GOSS GOSS 22,298,726 $3.7m1.17% 1.17% AddedShares held: Q3 2025 —, Q4 2025 0, Q1 2026 17.7m, Q2 2026 22.3m +4.6m +4,590,593 25.9%
22 MILESTONE PHARMACEUTICALS IN COM MIST MIST 2,538,474 $3.4m1.09% 1.09% NewShares held: Q3 2025 —, Q4 2025 0, Q1 2026 0, Q2 2026 2.5m
23 ADLAI NORTYE LTD SPONSORED ADS ANL ANL 226,415 $2.6m0.83% 0.83% NewShares held: Q3 2025 —, Q4 2025 0, Q1 2026 0, Q2 2026 226.4k
24 ATYR PHARMA INC COM NEW ATYR ATYR 3,576,334 $2.1m0.68% 0.68% NewShares held: Q3 2025 —, Q4 2025 0, Q1 2026 0, Q2 2026 3.6m
25 INSTIL BIO INC COM NEW TIL TIL 199,200 $1.5m0.49% 0.49% ReducedShares held: Q3 2025 —, Q4 2025 0, Q1 2026 322.9k, Q2 2026 199.2k -123.7k -123,679 -38.3%
26 TSCAN THERAPEUTICS INC COM TCRX TCRX 909,752 $891.6k0.28% 0.28% NewShares held: Q3 2025 —, Q4 2025 0, Q1 2026 0, Q2 2026 909.8k

Sold out since Q1 2026

SecurityTickerShares held beforeValue then
RELAY THERAPEUTICS INC RLAY RLAY 1,802,914 $17.9m1.8m shares
ORUKA THERAPEUTICS INC ORKA ORKA 237,048 $11.6m237.0k shares
PEPGEN INC PEPG PEPG 1,729,961 $3.1m1.7m shares
TENAYA THERAPEUTICS INC TNYA TNYA 4,000,000 $2.8m4.0m shares
KALARIS THERAPEUTICS INC KLRS KLRS 271,170 $1.6m271.2k shares
DIAMEDICA THERAPEUTICS INC DMAC DMAC 124,976 $846.1k125.0k shares
LOOP INDS INC LOOP LOOP 347,539 $361.4k347.5k shares